BONE BIOLOGICS CORPORATION (BBLG)

Import this data to Google Sheets with:

=jivedata("BBLG","financials")

Full statements spill as a table. For one cell: =jivedata("BBLG","Revenue") or =jivedata("BBLG","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

BONE BIOLOGICS CORPORATION

BBLG • CIK 0001419554

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-9,428.303	$-4,219.161	$-3,234.942	$-3,061.539
Nonoperating Income (Expense)	$479.572	$106.741	$125.951	$170.469
Net Income (Loss) Attributable to Parent	$-8,948.731	$-4,112.42	$-3,108.991	$-2,891.07
Preferred Stock Conversions, Inducements	—	$3,212.504	$3,212.504	$3,212.504
Net Income (Loss) Available to Common Stockholders, Basic	—	$-7,324.924	$-3,108.991	$-3,108.991
Weighted Average Number of Shares Outstanding, Basic	263,137	1,517,235	1,174,869	2,426,604
Research and Development Expense	$6,907.824	$2,130.385	$1,060.191	$895.349
General and Administrative Expense	$2,520.479	$2,088.776	$2,174.751	$2,166.19
Operating Expenses	$9,428.303	$4,219.161	$3,234.942	$3,061.539
Fair Value Adjustment of Warrants	$-892.693	$-51.081	$-3.967	$-1.867
Interest Income, Other	—	$55.66	$121.984	$168.602
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	232,154	2,048,580	2,971,814	2,750,227

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash	$3,026.569	$3,325.131	$5,334.322	$4,031.78
Assets	$3,737.763	$3,861.369	$5,796.135	$4,436.668
Interest Receivable	—	—	$9.895	$6.986
Prepaid Expense, Current	$10	$10	$10	$10
Liabilities	$831.402	$377.712	$418.587	$512.018
Common Stock, Value, Issued	$0.534	$2.953	$1.795	$1.81
Additional Paid in Capital	$83,814.785	$88,502.082	$93,506.122	$93,592.899
Retained Earnings (Accumulated Deficit)	$-80,908.958	$-85,021.378	$-88,130.369	$-89,670.059
Stockholders' Equity Attributable to Parent	$2,906.361	$3,483.657	$5,377.548	$3,924.65
Accounts Payable and Accrued Liabilities, Current	$360.662	$373.042	$417.884	$511.472
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	534,238	2,953,982	1,795,260	1,810,380

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-8,948.731	$-4,112.42	$-3,108.991	$-2,891.07
Net Cash Provided by (Used in) Operating Activities	$-9,555.904	$-4,124.935	$-2,691.15	$-2,628.868
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-4,511.743	$298.562	$2,009.191	$-2,608.688
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$3,026.569	$3,325.131	$5,334.322	$7,117.807
Share-based Payment Arrangement, Noncash Expense	$152.599	$188.819	$256.358	$164.612
Fair Value Adjustment of Warrants	$-892.693	$-51.081	$-3.967	$-1.867
Proceeds from Issuance of Common Stock	$5,044.161	$1,504.113	$4,352.792	$20.18
Proceeds from Debt, Net of Issuance Costs	—	—	$1,806.52	$1,806.52
Proceeds from Warrant Exercises	—	$0.662	$0.662	$0.662
Net Cash Provided by (Used in) Financing Activities	$5,044.161	$4,423.497	$4,700.341	$20.18
Increase (Decrease) in Prepaid Insurance	—	—	$-35.233	$-16.512
Increase (Decrease) in Accrued Interest Receivable, Net	—	—	$9.895	$9.895
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$255.876	$89.78	$91.025	$142.597

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("BBLG","financials")

Full statements spill as a table. For one cell: =jivedata("BBLG","Revenue") or =jivedata("BBLG","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.